Monica Ravindra Shah

Monica Ravindra Shah, MD, FACC, is the Chief Medical Officer at CTI Clinical Trial and Consulting Services since July 2024 and serves as an Adjunct Professor of Medicine at the University of Maryland School of Medicine since January 2010, specializing in Advanced Heart Failure and Cardiac Transplantation. Previously, Monica held senior leadership roles at Rocket Pharmaceuticals as Senior Vice President and AAV Global Program Head, at IQVIA as Vice President and Global Head of Cell and Gene Therapy, and at the National Center for Advancing Translational Sciences as Director of the Trial Innovation Network. Monica’s extensive experience includes leadership positions at the National Heart, Lung, and Blood Institute, MedStar Washington Hospital Center, Columbia University, and Duke University Health System. Monica holds degrees from multiple prestigious institutions, including a Doctor of Medicine from Brown Medical School and a Master of Arts in Journalism from Columbia University.